0 followers
Mythic Therapeutics’ innovative FateControl technology expands the potential of Antibody Drug Conjugates (ADCs) to destroy cancer and avoid normal cells.
Manifold Bio
2 followers
eGenesis
1 follower
School District of Philadelphia
4 followers
Mentor Collective
3 followers
Tessera Therapeutics
2 followers
Septerna
2 followers
FieldGuide
2 followers
89bio
2 followers
Neogene Therapeutics
2 followers
SolarBioTech
2 followers
Thurgood Marshall College Fund
1 follower
Explore companies